04063nam 2201057z- 450 991055751270332120231214132832.0(CKB)5400000000044428(oapen)https://directory.doabooks.org/handle/20.500.12854/77048(EXLCZ)99540000000004442820202201d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierRadiolabeled Compounds for Diagnosis and Treatment of CancerBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 electronic resource (262 p.)3-0365-2427-4 3-0365-2426-6 Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developing, and commercializing numerous radiopharmaceuticals for the imaging and therapy of cancer. Significant research is ongoing in academia and the pharmaceutical industry to develop more novel radiolabeled compounds as potential radiopharmaceuticals for unmet needs. This Special Issue aims to focus on all aspects of the design, characterization, evaluation, and development of novel radiolabeled compounds for the diagnosis and treatment of cancer and the application of new radiochemistry and methodologies for the development of novel radiolabeled compounds. Outstanding contributions presented in this Special Issue will significantly add to the field of radiopharmaceuticals.Research & information: generalbicsscChemistrybicsscpositron emission tomography (PET)pyrazolesfluorine-18radionuclidesPET probesimaging pharmaceuticalshypopharyngeal cancer188Re-liposomerepeated therapyNGSmicroRNAaprepitantradiopharmaceuticalsneurokinin 1 receptor antagonistradionuclide chelatorskidney uptakecleavable linkersneutral endopeptidase (NEP)renal brush border enzymesprostate-specific membrane antigen (PSMA)cancer imaging and therapysomatostatin analogsradiolabelingradionuclide therapyimagingadrenergic receptorpositron emission tomographyradiotracercholecystokinin-2 receptorminigastrinmolecular imagingtargeted radiotherapylutetium-177EpCAMradionuclideSPECTiodinePIBbreastcancerPETtarget-specific biomoleculesimmunoPET imaging pharmaceuticalsproduction processes124I-labeled monoclonal antibodiesradiotracersAAZTAscandium-44FAPSADPPPREPradioiodine labelingradioiodinationbiomoleculespeptidesproteinsmonoclonal antibodies123,124,125,131I-labeled molecules and biomoleculesResearch & information: generalChemistryKumar Krishanedt125816Kumar KrishanothBOOK9910557512703321Radiolabeled Compounds for Diagnosis and Treatment of Cancer3030930UNINA